Login to Your Account



Clinical trial to test cancer vaccine for glioma patients

By Sharon Kingman
Staff Writer

Thursday, June 26, 2014
A study in mice suggests it may be possible to develop a vaccine to protect against recurrence of glioma. Researchers in Germany hope to begin phase I trials of the vaccine in early 2015. When mice were given the candidate vaccine, it induced an appropriate immune response in the animals, and the experimental tumors used for the model stopped growing.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription